SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vivus: into single digits

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sal Milani who wrote (221)4/17/1998 1:58:00 PM
From: Mkilloran  Read Replies (1) of 1016
 
Sal .......if VVUS captures 20% of this huge ED market it will generate great earnings and pay off bigtime...Capacity of the New plant has been projected at ~6 mill units a qtr compared to todays current plant of 1.6 mill a qtr. The new plant in Ireland is moving foward and is expected to be online 4qtr 99 or early YR2000. That should bring capacity to ~12 Mill units a qtr in YR 2000....New and improved Muse in Phase iii trials expected to be marketed early 99....several new NON-ED products in the works....Let PFE bring in the patient to the DR's office...Vivus will do great with 20% of a potential 47 mill ED population.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext